HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial
Author:
Paul M Ridker,Jacques Genest,S Matthijs Boekholdt,Peter Libby,Antonio M Gotto,Børge G Nordestgaard,Samia Mora,Jean G MacFadyen,Robert J Glynn,John JP Kastelein
Date:
31 July–6 August 2010
Copyright © 2010 Elsevier Ltd. All rights reserved.